These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 356058)

  • 1. Experimental gram-negative bacterial sepsis: reevaluation of the ability of rough mutant antisera to protect mice.
    Greisman SE; DuBuy JB; Woodward CL
    Proc Soc Exp Biol Med; 1978 Jul; 158(3):482-90. PubMed ID: 356058
    [No Abstract]   [Full Text] [Related]  

  • 2. Treatment of E. coli and klebsiella bacteremia in agranulocytic animals with antiserum to a UDP-gal epimerase-deficient mutant.
    Ziegler EJ; Douglas H; Sherman JE; Davis CE; Braude AI
    J Immunol; 1973 Aug; 111(2):433-8. PubMed ID: 4577881
    [No Abstract]   [Full Text] [Related]  

  • 3. Cross-protective immunity to Gram-negative bacilli: studies with core glycolipid of Salmonella minnesota and antigens of Streptococcus pneumoniae.
    Young LS; Stevens P
    J Infect Dis; 1977 Aug; 136 Suppl():S174-80. PubMed ID: 19538
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cross-reactive antigens: their potential for immunization-induced immunity to Gram-negative bacteria.
    McCabe WR; Bruins SC; Craven DE; Johns M
    J Infect Dis; 1977 Aug; 136 Suppl():S161-6. PubMed ID: 330775
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potential use of shared antigens for immunization against gram-negative bacillary infections.
    McCabe WR; DeMaria A; Johns M
    Prog Clin Biol Res; 1980; 47():107-17. PubMed ID: 6163155
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Therapeutic and opsonizing effect of specific antibacterial immunoglobulins in experimental Klebsiella septicemia in mice].
    Trautmann M; Fischer GI; Hahn H
    Immun Infekt; 1984 Feb; 12(1):56-60. PubMed ID: 6398272
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The protective activity of anti-Proteus blood preparations].
    Nazarchuk LV; Koval' AI
    Fiziol Zh (1994); 1999; 45(6):37-9. PubMed ID: 10687080
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Experimental infection in rabbits evoked by Pseudomonas aeruginosa, Proteus mirabilis, Escherichia coli and Klebsiella pneumoniae treated with gentamicin, amikacin and sisomicin.
    Jeljaszewicz J; Włodarczak K; Bis W; Kazanowski A; Kuzniewski P; Molska J
    Zentralbl Bakteriol A; 1980 Aug; 247(3):347-52. PubMed ID: 6999802
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiserum against Escherichia coli J5: a re-evaluation of its in vitro and in vivo activity against heterologous gram-negative bacteria.
    Trautmann M; Hahn H
    Infection; 1985; 13(3):140-5. PubMed ID: 3897069
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibody to cell wall glycolipid of Gram-negative bacteria: induction of immunity to bacteremia and endotoxemia.
    Braude AI; Ziegler EJ; Douglas H; McCutchan JA
    J Infect Dis; 1977 Aug; 136 Suppl():S167-73. PubMed ID: 330776
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Elimination of Klebsiella pneumoniae and humoral immunity in immunization with the IS-4 immunostimulating mixture].
    Mansurova NL
    Zh Mikrobiol Epidemiol Immunobiol; 1986 Mar; (3):71-5. PubMed ID: 3518307
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Herd studies on coliform mastitis.
    Jasper DE; Dellinger JD; Bushnell RB
    J Am Vet Med Assoc; 1975 Apr; 166(8):778-80. PubMed ID: 804464
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Failure of antisera to J5 and R595 rough mutants to reduce endotoxemic lethality.
    Greisman SE; Johnston CA
    J Infect Dis; 1988 Jan; 157(1):54-64. PubMed ID: 2447200
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Experimental Gram-negative bacterial sepsis: optimal methylprednisolone requirements for prevention of mortality not preventable by antibiotics alone.
    Greisman SE
    Proc Soc Exp Biol Med; 1982 Sep; 170(4):436-42. PubMed ID: 6750617
    [No Abstract]   [Full Text] [Related]  

  • 15. [Proteus peritonitis-bacteremia in mice--a model for studying postvaccinal Proteus immunity].
    Zaĭtsev EV; Levina LA
    Zh Mikrobiol Epidemiol Immunobiol; 1990 Jul; (7):74-8. PubMed ID: 2251896
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship of structure to function in bacterial endotoxins: serologically cross-reactive components and their effect on protection of mice against some gram-negative infections.
    Ng AK; Chen CL; Chang CM; Nowotny A
    J Gen Microbiol; 1976 May; 94(1):107-16. PubMed ID: 778329
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bactericidal and opsonic activities of normal sheep serum against gram-negative bacteria.
    Mittal KR; Ingram DG
    Am J Vet Res; 1975 Aug; 36(08):1189-93. PubMed ID: 1098532
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Passive protection against heterologous gram-negative bacteria mediated by antiserum to epimeraseless Rc mutant of Salmonella minnesota.
    Konstantinov G; Karacholeva M; Eskenazy M; Ivanova R; Vassileva J; Naumova F; Tekelieva R; Strahilov D
    Ann Immunol (Paris); 1982; 133D(1):71-6. PubMed ID: 6760795
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nasal immunization with attenuated Salmonella Typhimurium expressing an MrpA-TetC fusion protein significantly reduces Proteus mirabilis colonization in the mouse urinary tract.
    Scavone P; Umpiérrez A; Maskell DJ; Zunino P
    J Med Microbiol; 2011 Jul; 60(Pt 7):899-904. PubMed ID: 21415205
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Experimental Klebsiella septicemia in mice: treatment with specific antibodies from the rabbit alone and in combination with gentamicin.
    Trautmann M; Müller-Leutloff Y; Hofstaetter T; Seiler FR; Hahn H
    Infection; 1985; 13(1):29-34. PubMed ID: 3886553
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.